Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BJOG : an International Journal of Obstetrics and Gynaecology|August 25, 2015
Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynaecological surgeryE M George, W M Burke, J Y Hou, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 17, 2016
Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trialK Kalinsky, T Zheng, H Hibshoosh, et al.BJOG : an International Journal of Obstetrics and Gynaecology|October 15, 2021
Minimally invasive surgery for suspected early-stage ovarian cancer; a cost-effectiveness studyS Dioun, L Chen, A Melamed, et al.Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|March 21, 2014
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancerK D Crew, K A Ho, P Brown, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trialK Kalinsky, J A Sparano, X Zhong, et al.The Pharmacogenomics Journal|September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancerS Yao, L E Sucheston, H Zhao, et al.Contemporary Clinical Trials|May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trialK D Crew, G L Anderson, K B Arnold, et al.Pageof 2